Rare diseases
Investigational molecules
Locations
Back to France29 clinical trials in Compiegne, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
FranceStudy of ribociclib with or without chemotherapy for patients with hormone receptor positive, HER2 negative early breast cancer at intermediate risk
FranceA study comparing trifluridine, tipiracil, and fruquintinib versus trifluridine and tipiracil alone for patients with metastatic stomach or esophageal cancer
FranceStudy of FOLFOX or FOLFIRI chemotherapy with fruquintinib or bevacizumab as second-line treatment for patients with metastatic colorectal cancer
FranceStudy Comparing Elranatamab and Lenalidomide with Daratumumab and Lenalidomide for Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients
FranceStudy on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment
FranceStudy Comparing Continuous and Fixed Duration Therapy with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Relapsed Multiple Myeloma
FranceStudy on Dexamethasone for Patients with Advanced Relapsed or Refractory Multiple Myeloma
FranceStudy on Using Oxaliplatin, Fluorouracil, and Folinic Acid for Treating Stage II Colon Cancer in Patients with Positive Circulating Tumor DNA
FranceStudy Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma
FranceStudy Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults
FranceStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on colorectal cancer, breast cancer, and renal cell carcinoma treatments. Studies evaluate innovative therapeutic approaches including targeted therapies and immunotherapy combinations.
Particular emphasis on personalized treatment approaches and circulating tumor DNA analysis for treatment decisions.
Innovative research targeting atherosclerotic cardiovascular disease and related conditions. Trials evaluate new therapeutic agents for reducing cardiovascular events and managing risk factors.
Focus on preventive measures and novel treatments for high-risk cardiovascular patients.
Studies investigating treatments for Mycobacterium infections and related pulmonary conditions. Evaluation of innovative antibiotic therapies and treatment protocols.
Emphasis on comparing different therapeutic approaches for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
